Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 12Solid Tumors 1Shock, Septic 1Neoplasms 1Metabolic Syndrome 1Menstruation Disturbances 1Insulin Resistance 1Infertility, Female 1Hodgkin Disease 1Cardiovascular Diseases 1

Interventions

Vasopressins 1Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization 1Saline Solution 1Norepinephrine 1Methylene Blue 1Contraceptives, Oral 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Shock, Septic × Contraceptives, Oral × Clear all
NCT06005558 2024-07-05

Low Dose Versus High Dose Methylene Blue in Septic Patients

National Cancer Institute, Egypt

Phase 2/3 Completed
90 enrolled

Shock, Septic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡